Release Date: 04/10/16 18:03 Summary: Notification of extension of convening period-KBL.AX Price Sensitive: No Download Document 100.36KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%